During the last three months, 4 analysts shared their evaluations of Evolus (NASDAQ:EOLS), revealing diverse outlooks from bullish to bearish.
The table below provides a snapshot of their recent ratings, showcasing how sentiments have evolved over the past 30 days and comparing them to the preceding months.
| Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
|---|---|---|---|---|---|
| Total Ratings | 3 | 1 | 0 | 0 | 0 |
| Last 30D | 1 | 1 | 0 | 0 | 0 |
| 1M Ago | 0 | 0 | 0 | 0 | 0 |
| 2M Ago | 2 | 0 | 0 | 0 | 0 |
| 3M Ago | 0 | 0 | 0 | 0 | 0 |
The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $22.75, a high estimate of $27.00, and a low estimate of $20.00. Witnessing a positive shift, the current average has risen by 4.6% from the previous average price target of $21.75.
Understanding Analyst Ratings: A Comprehensive Breakdown
The analysis of recent analyst actions sheds...
Login or create a forever free account to read this news
Sign up/Log in
